| Location: | Maryland |
|---|---|
| Posted: | Feb 6, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Contract: | Awards |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | 75N91026P00006 |
| Publication URL: | To access bid details, please log in. |
This is a Firm Fixed Price Purchase Order. The National Cancer Institute (NCI) awarded a purchase order to Ferox LLC to obtain a Bond Rx Controller for a clinical instrument (Leica Bond) Automated Immunohistochemistry stainer annual (1 year warranty included) and recommended Preventative Maintenance post-instrument relocation (with PM Kit included). The instrument will be used for validation of clinical IHC target markers for diagnostic and in some cases enrollment to NIH clinical trials. In the clinical research application, the Bond Rx instrument will be used for critical research in rare tumor identification and subsequent development of therapeutic mechanisms for patients undergoing treatments.

With GovernmentContracts, you can:
...Follow Notice of Intent: Genomic research digital marketing campaign Active Contract Opportunity...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 7/27/2026
...Follow Subscription Access to a Market Research Database in accordance with the attached ...
COMMERCE, DEPARTMENT OF
Bid Due: 7/31/2026
...Small Business Innovation Research (SBIR) Program. The SBIR Program is a three-phase program ...
Department of Commerce
Bid Due: 1/22/2038
...Follow Research Coordinator Support Services for NHLBI Novel Structural Heart Intervention...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 7/30/2026